๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ulcerative Colitis
Clinical trial register · Israel

Ulcerative Colitis Trials in Israel, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2428 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2428
Studies in scope
all four open statuses
1246
Recruiting now
open to new participants
455
Lead sponsors
across recruiting studies
Top sites
Jerusalem 13 Haifa 11 Petah Tikva 11 Tel Aviv 8 Beersheba 8
Narrow the registerReset
Recruitment status
Phase
Site location
Jerusalem13 Haifa11 Petah Tikva11 Tel Aviv8 Beersheba8
All 17 locations
Target enrolment
to

Ulcerative Colitis trials in Israel

16 of 2428 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086Ulcerative Colitis, Obesity or Overweight
Eli Lilly and Company
Phase 3
350
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, แบ”erifin
2025-06-26
Active, closed
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
NCT06880744Ulcerative Colitis
AbbVie
Phase 3
573
Petah Tikva, แบ”erifin, Ashdod, Beersheba, Ramat Gan, Tel Aviv, Haifa
2025-06-17
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Beer Yaaqov, Beersheba, Haifa, Jerusalem, Nahariya
2025-05-27
Active, closed
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
NCT06254950Ulcerative Colitis
Takeda
Phase 2
213
Ashdod, Beersheba, Jerusalem, Ramat Gan
2024-03-29
Active, closed
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
NCT06257875Ulcerative Colitis
AbbVie
Phase 2
156
แบ”erifin, Jerusalem, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2024-03-23
Active, closed
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059Ulcerative Colitis
Merck Sharp & Dohme LLC
Phase 3
1,020
Afula, Ashkelon, Haifa, Holon, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2023-10-25
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT05442567Ulcerative Colitis, Crohn's Disease
Takeda
Phase 3
240
Jerusalem, Beersheba, Haifa, Petah Tikva
2023-05-16
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Afula, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Rehovot, Tel Aviv
2023-01-16
Active, closed
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
NCT05494606Ulcerative Colitis
AbbVie
Observational
785
Beer Ya'akov, Haifa, Beersheba, Tel Aviv, Petah Tikva
2022-08-15
Active, closed
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
NCT04835506Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Beth Israel Deaconess Medical Center
Phase 4
124
2021-11-01
Active, closed
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
NCT04624230Ulcerative Colitis
Pfizer
Phase 3
118
Beโ€™er Yaโ€˜aqov, Haifa, Jerusalem, Petah Tikva, Tel Aviv
2021-08-12
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Eli Lilly and Company
Phase 3
150
Beersheba, Haifa, Jerusalem, Petah Tikva, แบ”erifin
2021-05-26
Active, closed
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445Ulcerative Colitis
Janssen Research & Development, LLC
Phase 2/3
1,064
Haifa, Holon, Jerusalem, Nahariya, Tel Aviv
2019-09-26
Active, closed
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03950232Ulcerative Colitis
Pfizer
Phase 3
896
Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Rehovot
2019-09-05
Active, closed
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
NCT03519945Ulcerative Colitis
Eli Lilly and Company
Phase 3
1,058
Beersheba, Jerusalem, Nahariya, Rehovot, Tel Aviv, แบ”erifin
2018-07-18
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-israel/condition/ulcerative-colitis

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,428 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Ulcerative Colitis.

How many Ulcerative Colitis trials are recruiting in Israel?

4 of the 16 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ulcerative Colitis), 16 studies
PhaseStudiesRecruitingShare
Phase 310362.5%
Phase 23118.8%
Observational106.3%
Phase 2/3106.3%
Phase 4106.3%

Most active sponsors

Lead sponsors with the most studies (Ulcerative Colitis)
Lead sponsorStudiesRecruiting
AbbVie40
Eli Lilly and Company32
Pfizer20
Takeda21
Abivax S.A.10
Beth Israel Deaconess Medical Center10
Janssen Research & Development, LLC10
Merck Sharp & Dohme LLC10
Spyre Therapeutics, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.